These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 21467128

  • 21. Sympathetic activity in chronic kidney disease patients is related to left ventricular mass despite antihypertensive treatment.
    Siddiqi L, Prakken NH, Velthuis BK, Cramer MJ, Oey PL, Boer P, Bots ML, Blankestijn PJ.
    Nephrol Dial Transplant; 2010 Oct; 25(10):3272-7. PubMed ID: 20360012
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Aliskiren reduces morning blood pressure in hypertensive patients with diabetic nephropathy on hemodialysis.
    Takenaka T, Okayama M, Kojima E, Nodaira Y, Arai J, Uchida K, Kikuta T, Sueyoshi K, Hoshi H, Watanabe Y, Takane H, Suzuki H.
    Clin Exp Hypertens; 2013 Oct; 35(4):244-9. PubMed ID: 23534458
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
    Villamil A, Chrysant SG, Calhoun D, Schober B, Hsu H, Matrisciano-Dimichino L, Zhang J.
    J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
    [Abstract] [Full Text] [Related]

  • 27. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
    Ruzicka M, Coletta E, Leenen FH.
    Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
    [Abstract] [Full Text] [Related]

  • 28. Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure.
    Neumann J, Ligtenberg G, Oey L, Koomans HA, Blankestijn PJ.
    J Am Soc Nephrol; 2004 Nov; 15(11):2902-7. PubMed ID: 15504943
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunction.
    Ito S, Nakura N, Le Breton S, Keefe D.
    Hypertens Res; 2010 Jan; 33(1):62-6. PubMed ID: 19927154
    [Abstract] [Full Text] [Related]

  • 32. (99m)Tc-DTPA scintigraphy assesses the absence of glomerular filtration rate impairment of Aliskiren in high-risk hypertensive subjects. A 12-month follow-up study.
    Mazza A, Montemurro D, Maffione AM, Vescovo G, Rampin L, Zuin M, Schiavon L, Camerotto A, Marzola MC, Fiorini F, Rubello D.
    Minerva Cardioangiol; 2014 Aug; 62(4):311-20. PubMed ID: 25012100
    [Abstract] [Full Text] [Related]

  • 33. What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?
    de la Sierra A, Salazar J.
    Adv Ther; 2011 Sep; 28(9):716-27. PubMed ID: 21809181
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment.
    Neumann J, Ligtenberg G, Klein IH, Boer P, Oey PL, Koomans HA, Blankestijn PJ.
    Hypertension; 2007 Mar; 49(3):506-10. PubMed ID: 17224471
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.